Search results for "Hera"

showing 10 items of 14928 documents

Calidad de la farmacoterapia y seguridad de los pacientes en hemodiálisis tratados con estimulantes eritropoyéticos

2008

Objective: To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are treated with erythropoiesis-stimulating agents. Method: Observational, longitudinal study. Retrospective analysis (period A) and prospective analysis (period B) following implementation of the programme for haemoglobin values and monthly erythropoiesis- stimulating agent dosage. The proportion of patients with haemoglobin values within the target range (10-5-12.5 g/dl) and those with values above the safety limit (≥ 12.5g/dl) were compared every four months and the average percentage of time with haemoglobin values within the ta…

PharmacologyLongitudinal studymedicine.medical_specialtybusiness.industryHaemoglobin levelsChronic renal diseaseTarget rangePharmacotherapyInternal medicineRetrospective analysisMedicineIn patientEvery Four MonthsbusinessFarmacia Hospitalaria
researchProduct

MR-Angiographie peripherer Gefäße mit automatischer Verschiebetisch-Technik bei 1.0 T im Vergleich zur i. a. DSA

1999

PURPOSE Contrast-enhanced (CE) 3D-MR angiography of peripheral arteries was performed in 8 patients with peripheral arterial occlusive disease by applying a new tracking technique on a 1.0 T system (Magnetom Harmony, Siemens). The studies were compared with intra-arterial digital angiography as gold standard. MATERIALS AND METHODS Imaging of the distal aorta, pelvis, upper and lower limb arteries was accomplished with a Flash-3D-sequence (TR/TE = 6.2/3.2 ms) within 26 s acquisition time of each region after a single bolus of 30 ml contrast agent. Individual circulation time was determined by a test bolus before each examination. RESULTS 112 vessel segments were evaluated. MR angiography ach…

Aortamedicine.medical_specialtymedicine.diagnostic_testbusiness.industryVascular diseaseMr angiographyGold standard (test)medicine.diseasePeripheralStenosismedicine.anatomical_structuremedicine.arteryAngiographymedicineRadiology Nuclear Medicine and imagingRadiologybusinessArteryRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Prognostic factors in the treatment of Ewing's sarcoma

1987

From 1981 up to February 1985, a total of 93 protocol patients entered the study CESS 81. The protocol recommended an initial 18-week period of polychemotherapy (VACA) followed by local therapy and two additional cycles of chemotherapy. Local therapy consisted either of radical surgery or of incomplete resection plus postoperative irradiation with 36 Gy or of radiotherapy alone (46 and 60 Gy). Centrally located lesions were always irradiated with 60 Gy. This article summarizes the data after 5 years. Data of 93 patients were analysed in October 1986 after a median follow-up of 37 months. The projected 5-year survival is 50%. The relapse rate was 42%, distant relapses occurred in 19%, local …

medicine.medical_specialtyChemotherapybusiness.industryPaediatric oncologymedicine.medical_treatmentPostoperative irradiationEwing's sarcomaHematologymedicine.diseaseSurgeryRadiation therapyOncologyMedicineCombined Modality TherapyRadiology Nuclear Medicine and imagingSarcomaRadical surgerybusinessRadiotherapy and Oncology
researchProduct

L’échographie pulmonaire : une aide au diagnostic et au contrôle de la réponse à la kinésithérapie. À propos d’un cas

2017

Introduction L’echographie pulmonaire pourrait etre un outil interessant pour le kinesitherapeute puisqu’elle pourrait permettre d’ameliorer l’indication et le suivi du traitement par kinesitherapie respiratoire [1] . A notre connaissance, aucune etude n’a evalue l’impact de l’echographie pulmonaire sur le processus de decision clinique du kinesitherapeute. Ce rapport de cas aborde l’interet de l’echographie pulmonaire en kinesitherapie respiratoire chez une patiente avec une consolidation pulmonaire. Materiel, population et methode Ce rapport de cas est ecrit suivant les recommandations de « The CARE guideline » [2] . La patiente etait une femme de 68 ans, non intubee et hospitalisee dans …

03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisRehabilitationPhysical Therapy Sports Therapy and Rehabilitation030212 general & internal medicineKinésithérapie, la Revue
researchProduct

Lebermetastasen kolorektaler Karzinome - wie oft kann man operieren?

2007

Recurrent liver metastases of colorectal carcinoma are frequent. The repeat hepatectomy is superior to other therapeutic options. In about 20 % of patients with recurrent liver metastases a complete resection (R 0) is possible. The morbidity of repeat hepatectomy is similar to that of first hepatectomy. The 5-year survival rate after repeat hepatectomy ranges between 30 and 40 %. Often in the follow-up additional operations become necessary for extrahepatic recurrencies. For determination of the optimal therapy an interdisciplinary approach must be chosen.

medicine.medical_specialtybusiness.industryColorectal cancermedicine.medical_treatmentRepeat hepatectomymedicine.diseaseComplete resectionSurgeryText miningmedicineSurgeryOperative therapyHepatectomybusinessSurvival rateZentralblatt für Chirurgie
researchProduct

1.12 C-Reactive Protein is Associated with Aortic Stiffness Independently of Microalbuminuria in Essential Hypertension

2008

medicine.medical_specialtyPharmacotherapybusiness.industryInternal medicineInternal MedicinemedicineCardiologyInflammationmedicine.symptomCardiology and Cardiovascular MedicinebusinessHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenoc…

2021

4066 Background: CheckMate 649 (NCT02872116) is a randomized, open label phase 3 study in first line (1L) GC/GEJC/EAC. Prespecified interim results showed statistically significant improvement in overall survival (OS) and progression-free survival (PFS) for N+C vs C in all randomized pts and pts whose tumors expressed programmed death-ligand 1 combined positive score (CPS) ≥ 5. We present interim HRQOL results for CPS ≥ 5 pts, included as exploratory in the study. Methods: HRQOL was assessed using EQ-5D-3L (EQ-5D) and Functional Assessment of Cancer Therapy–Gastric Cancer (FACT-Ga). Assessments were performed at baseline (BL), every 6 weeks during treatment, and during follow-up. Change fr…

Health related quality of lifeCancer ResearchChemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCheckmatePhases of clinical researchEsophageal adenocarcinomaCancerGastroesophageal Junctionmedicine.diseaseGastroenterologyOncologyInternal medicineMedicineNivolumabbusinessJournal of Clinical Oncology
researchProduct

Motivation zur psychosomatisch-psychotherapeutischen Bearbeitung von beruflichen Belastungen - Entwicklung und Validierung eines Fragebogens

2005

Background There is a lack of questionnaires assessing the motivation of inpatients to scrutinize occupational stresses and deal with them as part of their psychotherapeutic treatment. Work-related stress contributes significantly to the development of mental disorders. Vocational reintegration is an outcome criterion for the success of vocational rehabilitation. Patients are often not motivated for dealing with occupational stresses during inpatient medical rehabilitation. Therefore it is necessary to assess patient motivation at the beginning of treatment, in order to assign them to specific interventions, e. g. promoting motivation. Method A questionnaire (Fragebogen zur berufsbezogenen …

Predictive validityCoping (psychology)PsychotherapistRehabilitationSick rolemedicine.medical_treatmentRehabilitationPsychological interventionPatient satisfactionCronbach's alphaVocational educationmedicinePsychologyClinical psychologyDie Rehabilitation
researchProduct

P–435 LH preserves oocyte-granulosa cell communication in mouse ovaries exposed to chemotherapy with alkylating agents

2021

Abstract Study question Does Luteinizing Hormone (LH) protect the follicular endowment and growth by improving oocyte-granulosa cell (GC) communication of follicles exposed to chemotherapy at the primordial stage? Summary answer LH treatment protects mouse primordial follicles against alkylating agents by preventing the chemotherapy-induced follicular depletion and the impairment of oocyte-GC communication during follicular growth. What is known already Impaired folliculogenesis is one of the most common deleterious side effects of alkylating agents in ovaries. Bidirectional communication between the oocyte and surrounding GCs is crucial for oocyte development. Therefore, defective gap junc…

AndrologyChemotherapymedicine.anatomical_structureReproductive MedicineChemistrymedicine.medical_treatmentGranulosa cellRehabilitationmedicineObstetrics and GynecologyOocyteHuman Reproduction
researchProduct

Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes

1996

In the present study, we investigated the effect of interferon-alpha (IFN-alpha) on the expression of interleukin-10 (IL-10) mRNA and protein synthesis in human monocytes and CD4+ T cells. In mononuclear cells, IFN-alpha induced expression of IL-10 mRNA and further enhanced lipopolysaccharide (LPS)-stimulated IL-10 expression. In purified monocytes, a strong expression of IL-10 mRNA induced by LPS was not further enhanced by IFN-alpha. In highly purified CD4+ T cells, IFN- alpha upregulated IL-10 mRNA upon activation with phytohemagglutinin and phorbol myristate acetate. In purified monocytes, an effect of IFN- alpha on IL-10 protein synthesis was dependent on costimulation with LPS. Maxima…

LipopolysaccharideMonocytemedicine.medical_treatmentCD3ImmunologyCD28Alpha interferonCell BiologyHematologyBiologyBiochemistryMolecular biologyPeripheral blood mononuclear cellchemistry.chemical_compoundInterleukin 10medicine.anatomical_structureCytokinechemistryImmunologymedicinebiology.proteinBlood
researchProduct